Why Does Diabetes Cause Acid Reflux?

Diabetes raises the risk of gastroesophageal reflux disease (GERD) by roughly 60 percent compared to people without diabetes, according to a meta-analysis pooling data from multiple studies across different populations.¹ The connection is not a single broken mechanism but a pileup of overlapping problems: nerve damage that weakens the esophagus, a stomach that empties too slowly, excess body weight pressing on the abdomen, and even the medications used to treat diabetes itself. Understanding which of these factors is at work matters, because the management approach changes depending on the cause.

Nerve Damage and the Esophagus

The most direct link between diabetes and acid reflux runs through the nerves. Chronically elevated blood sugar damages small nerve fibers throughout the body, a complication known as diabetic neuropathy. When those damaged nerves happen to serve the esophagus, two things go wrong at once: the muscular contractions that push food downward become weaker and less coordinated, and the valve at the bottom of the esophagus (the lower esophageal sphincter) loses its ability to stay tightly shut.

Studies using esophageal pressure measurements in people with diabetes have found reduced sphincter pressure and weaker peristaltic waves, the rhythmic squeezing that normally moves food from mouth to stomach.² When peristalsis falters, food and acid linger in the esophagus longer than they should. When the sphincter is slack, stomach contents can wash back upward with less resistance. Research has found that these esophageal motility disturbances are most common in people who already show signs of peripheral or autonomic neuropathy elsewhere in the body, and that there is a measurable correlation between the severity of nerve conduction problems and the degree of esophageal dysfunction.³ Common findings include absent primary peristalsis, simultaneous or repetitive contractions in the esophageal body, and slower contraction velocity.⁴

The practical takeaway is that acid reflux in someone with diabetes is not always a standalone stomach problem. If you have signs of neuropathy in your hands and feet, or if you have been diagnosed with autonomic neuropathy affecting your heart rate or blood pressure, your esophagus is likely affected too. Among people with type 2 diabetes and confirmed neuropathy, close to 59 percent reported GERD symptoms, compared to about 33 percent of those without neuropathy.⁵

Gastroparesis and the Backup Effect

Gastroparesis, where the stomach empties food far more slowly than normal, is one of the better-known gastrointestinal complications of diabetes. Its connection to acid reflux is mechanical and straightforward: when food sits in the stomach longer than it should, the stomach stays distended. That distension increases the pressure pushing against the lower esophageal sphincter and increases the total volume of material available to reflux. On top of that, prolonged contact between food and the stomach lining stimulates more acid secretion, so the refluxate is both larger in volume and more acidic.⁶

This creates a particularly frustrating clinical situation. Standard acid reflux treatments like proton pump inhibitors reduce acid production, but they do nothing about the underlying motility problem. If gastroparesis is the main driver of your reflux, acid-suppressing drugs may take the edge off the heartburn without fixing the root cause. Meanwhile, some of the dietary advice that helps ordinary reflux, like eating larger, less frequent meals, can actually make gastroparesis worse. People with diabetes-related gastroparesis generally do better with smaller, more frequent meals that are lower in fat and fiber, since both fat and fiber slow gastric emptying further.

Diagnosing gastroparesis typically involves a gastric emptying study, where you eat a standardized meal containing a small amount of a tracer and imaging tracks how fast your stomach clears it. This scintigraphy test is considered the gold standard for confirming delayed gastric emptying.⁷ If you have diabetes and acid reflux that does not respond well to standard treatment, gastroparesis is worth investigating.

How Excess Weight Compounds the Problem

Obesity is one of the strongest standalone risk factors for GERD in any population, and a large share of people with type 2 diabetes carry excess weight, especially around the abdomen. A Mendelian randomization study, which uses genetic variants to tease apart cause and effect, found that higher BMI had a strong causal relationship with GERD, with roughly a 49 percent increase in odds for each standard-deviation rise in BMI. Type 2 diabetes itself showed an independent but smaller causal effect on GERD even after accounting for body weight.⁸

Abdominal fat physically increases the pressure inside the abdomen, which pushes the stomach upward and forces contents against the lower esophageal sphincter. Waist circumference, specifically, showed its own association with GERD in the same analysis, supporting the idea that it is visceral fat distribution, not just total body weight, that matters. This means that for many people with type 2 diabetes, acid reflux is being driven by two independent forces at once: the metabolic and neurological effects of diabetes itself, and the mechanical pressure of abdominal obesity. Losing even a modest amount of weight can meaningfully reduce reflux episodes, which is why weight management keeps showing up in GERD guidelines regardless of diabetes status.

Blood Sugar Swings and Nighttime Reflux

The relationship between blood sugar and reflux is not just about long-term nerve damage. Short-term fluctuations in glucose levels appear to affect the esophagus in real time. Research in adolescents with type 1 diabetes found that nights with unstable blood sugar, where glucose swung widely, were associated with dramatically more acid reflux events compared to nights with stable glucose. Those with high nighttime glycemic variability had longer total esophageal acid exposure, more prolonged reflux episodes lasting over five minutes, and a much higher rate of abnormal acid reflux overall.⁹

This finding is striking because it shows up in young people with type 1 diabetes who have not yet developed the chronic neuropathy or gastroparesis that typically explain reflux in older adults with type 2 diabetes. The mechanism is thought to involve acute effects of high blood sugar on the autonomic nerves controlling the esophagus and stomach. Even temporarily elevated glucose can impair nerve signaling enough to relax the lower esophageal sphincter or slow motility. For anyone with diabetes who notices that reflux tends to be worse at night, tighter overnight glucose control may help more than an extra dose of antacid.

When Diabetes Masks Its Own Damage

One of the more counterintuitive problems is that diabetes can make reflux simultaneously worse and harder to detect. The same nerve damage that weakens the esophageal muscles also dulls the esophagus’s ability to sense acid. Research has found that people with long-standing diabetes show altered pain thresholds in the esophagus, tolerating higher intensities of electrical stimulation before perceiving discomfort.¹⁰ The perception of heartburn and regurgitation may be blunted, even when acid exposure is objectively elevated.¹¹

This creates a real clinical blind spot. A person with diabetes may have significant esophageal acid exposure but report only mild or no symptoms. By the time symptoms become noticeable, the damage to the esophageal lining may be more advanced. For this reason, some gastroenterologists have a lower threshold for endoscopy or pH monitoring in people with diabetes, especially those with known neuropathy, rather than relying on symptom severity alone to guide testing.

Diabetes Medications That Can Trigger Reflux

The drugs used to manage diabetes can themselves contribute to reflux, and this is an area where the evidence has been evolving quickly. GLP-1 receptor agonists, the class that includes semaglutide (Ozempic, Wegovy) and liraglutide, have become some of the most widely prescribed diabetes and weight-loss medications in the world. These drugs slow gastric emptying as part of their mechanism of action, which is one reason they reduce appetite and aid blood sugar control. But that same slowed emptying can promote reflux by the same mechanism as gastroparesis.

A large population-based cohort study comparing people with type 2 diabetes who started GLP-1 receptor agonists versus those who started SGLT-2 inhibitors found that GLP-1 users had a 27 percent higher rate of developing GERD and a 55 percent higher rate of GERD-related complications over a median follow-up of three years.¹² In absolute terms, the extra risk was small: about 0.7 additional GERD cases per 100 patients. But given the tens of millions of people now taking these medications, even a small increase in risk translates into a lot of new reflux cases. If you started a GLP-1 medication and noticed new or worsening heartburn, the drug itself could be contributing, and it is worth discussing with your prescriber rather than simply adding an antacid on top.

Metformin, still the most commonly prescribed first-line diabetes drug, can also cause upper gastrointestinal symptoms including nausea and a burning sensation, though these tend to improve over time and are less clearly linked to true acid reflux as opposed to general stomach irritation. The distinction matters for treatment decisions.

Longer-Term Esophageal Risks

Chronic acid reflux in anyone raises the risk of Barrett’s esophagus, a condition where the esophageal lining changes in ways that can predispose to esophageal cancer. The interaction between diabetes and these outcomes is concerning. A pooled analysis from the International Barrett’s and Esophageal Adenocarcinoma Consortium found that diabetes was associated with about a 30 percent increased risk of esophageal adenocarcinoma and esophagogastric junctional adenocarcinoma combined. Among people who also had regurgitation symptoms, the risk jumped to 63 percent higher.¹³

Interestingly, the same analysis did not find a consistent link between diabetes and Barrett’s esophagus itself. The finding that diabetes is associated with the cancer but not the precursor condition is still being worked out. One explanation is that the blunted symptom perception discussed earlier means people with diabetes are less likely to seek evaluation and receive a Barrett’s diagnosis even when the tissue changes are present. Another possibility is that diabetes promotes cancer through metabolic pathways, like insulin resistance and chronic inflammation, that act independently of the Barrett’s pathway. Either way, people with diabetes and persistent reflux symptoms, especially regurgitation, may warrant closer surveillance than the general population.

What Happens When Surgery Is the Answer

For people with severe GERD that does not respond to medication, anti-reflux surgery, most commonly Nissen fundoplication, is an option. The question for people with diabetes is whether delayed gastric emptying undermines the results. A study comparing surgical outcomes in people with delayed versus normal gastric emptying found that reflux symptom relief was essentially equivalent between the two groups, with about 86 percent of those with delayed emptying and 91 percent of those with normal emptying reporting complete relief at nearly two years of follow-up.¹⁴

The catch was that people with delayed gastric emptying experienced higher rates of gas bloat, nausea, and abdominal pain after surgery. Fundoplication works by wrapping the top of the stomach around the lower esophagus to reinforce the sphincter. When the stomach already empties slowly, creating a tighter valve can make it even harder for gas and food to move through. So while surgery can still solve the reflux problem, it may trade one set of symptoms for another in someone with underlying gastroparesis. This is why many surgeons will order a gastric emptying study before proceeding with anti-reflux surgery in anyone with diabetes, to set realistic expectations and sometimes to address the motility issue first.

How the Subgroup Patterns Break Down

The diabetes-GERD link is not uniform across all populations. The meta-analysis that established the roughly 60 percent overall risk increase also found that the association was stronger in people under 50, with about a 70 percent increased odds, and in populations from Eastern countries.¹ The age finding is a bit surprising. You might expect reflux risk to climb with duration of diabetes, and therefore with age, but the stronger association in younger people could reflect the fact that GERD is already so common in older adults for other reasons (medication use, hiatal hernia, reduced mobility) that the additional contribution of diabetes is harder to isolate statistically. In younger adults, diabetes may be one of the few strong risk factors present, making its influence more visible.

The geographic variation likely reflects differences in diet, body composition, prevalence of Helicobacter pylori infection (which paradoxically may protect against reflux in some populations), and possibly genetic differences in gut motility. These subgroup findings reinforce that there is no single explanation for why diabetes promotes reflux. The dominant mechanism probably differs from person to person: nerve damage in one, gastroparesis in another, medication effects in a third, and abdominal obesity in many.

The Broader Gut Picture

Acid reflux is only one piece of a much larger pattern of gastrointestinal complications in diabetes. The same autonomic nerve damage and motility disruptions that affect the esophagus can affect the entire digestive tract, from the stomach through the small intestine to the colon. Bacterial overgrowth in the small intestine, constipation, diarrhea, and fecal incontinence are all more common in people with diabetes.¹⁵ When someone with diabetes presents with acid reflux, it is worth asking about the rest of the digestive system too. Bloating, early fullness, irregular bowel habits, and unexplained changes in nutrient absorption can all point to the same underlying autonomic dysfunction. Treating each symptom in isolation, antacid for the reflux, laxative for the constipation, anti-diarrheal for the diarrhea, misses the common thread and can sometimes make one problem worse while addressing another.

For people managing diabetes alongside persistent reflux, the most productive conversations with a doctor tend to focus not just on acid suppression but on the broader motility picture: whether gastric emptying is normal, whether blood sugar control is tight enough to avoid acute nerve effects, whether current medications could be contributing, and whether weight management could relieve some of the mechanical pressure. The reflux is real and treatable, but in the context of diabetes, it is rarely just an acid problem.